Eurofins
Corporate brand
UnclaimedGlobal leader in food safety testing
Last updated October 6, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Eurofins is the operating brand of Eurofins Scientific, a multinational laboratory and analytical testing group founded in 1987 by Gilles Martin. The company developed from a scientific testing business into a large international network of laboratories and specialist service companies. Its work supports decisions involving public health, food safety, environmental protection, pharmaceutical development, clinical diagnosis, agriculture, cosmetics, and a range of industrial applications. The group’s services are primarily business-to-business and institution-facing rather than consumer products. Eurofins laboratories analyze samples and materials, generate scientific data, and provide related laboratory, research, validation, inspection, and advisory services. Depending on the market and local operating company, its work can include testing food ingredients and finished products, detecting contaminants, evaluating environmental samples, supporting pharmaceutical research and manufacturing, performing clinical and genetic diagnostics, and assessing cosmetics and consumer goods. A major feature of the Eurofins model is its decentralized international laboratory network. Local and specialist businesses operate close to customers and regulatory environments while sharing a broader brand, scientific infrastructure, and group platform. This structure allows Eurofins to cover many technical disciplines and geographic markets, although the precise services offered differ by laboratory and country. Eurofins has expanded internationally through organic development and acquisitions of laboratories and specialist testing businesses. Its growth has broadened the group’s capabilities across analytical chemistry, microbiology, molecular biology, genomics, clinical diagnostics, pharmaceutical services, and environmental testing. The Eurofins name therefore represents a portfolio of related laboratory businesses rather than a single standardized consumer offering. The group is headquartered in Luxembourg and its shares are traded on Euronext Paris under the ticker ERF.PA. Eurofins presents its purpose around supporting health, safety, and environmental protection through expert laboratories. Its principal competitive proposition is the combination of technical specialization, broad geographic coverage, laboratory capacity, and the ability to provide regulated testing and analytical data to organizations that need independent scientific results.
History
Eurofins was established in 1987 by Gilles Martin. The business was created around analytical science and subsequently developed into an international provider of laboratory testing and related services. From its early base in Europe, the group expanded its technical scope and geographic reach by building and acquiring specialist laboratories. The company’s growth reflects the increasing importance of independent testing in regulated and safety-sensitive sectors. Food producers and retailers require analysis for pathogens, residues, allergens, authenticity, and composition. Pharmaceutical companies need laboratory support across research, development, manufacturing, validation, and quality control. Public authorities and industrial customers rely on environmental analysis to measure pollutants and demonstrate compliance. Clinical and genetic testing adds a further health-related area in which accuracy, traceability, and specialized scientific expertise are central. Rather than operating as one uniform laboratory, Eurofins developed a network model. Individual businesses and laboratories retain market-specific expertise and customer relationships while operating within the wider Eurofins Scientific group. This approach supports specialization in fields such as genomics, microbiology, analytical chemistry, pathology, environmental science, and pharmaceutical testing. It also enables the group to serve customers across multiple countries and regulatory systems. Over time, Eurofins broadened its portfolio beyond traditional food and environmental analysis. Its activities came to include pharmaceutical and biopharmaceutical services, clinical diagnostics, molecular and genetic testing, cosmetics and consumer-product analysis, agricultural testing, and specialist industrial services. The company’s presence in these markets is delivered through a variety of local and specialist Eurofins businesses, so service names and capabilities vary by jurisdiction. Eurofins Scientific became a publicly traded company on Euronext Paris, where its shares trade under ERF.PA. The listed group continued to pursue international expansion and laboratory-network development. Its corporate identity is closely associated with analytical independence, scientific measurement, regulatory support, and a distributed network of expert laboratories. Today, Eurofins describes itself as a leading provider of analytical testing services. Its business supports organizations concerned with health, safety, product quality, environmental protection, and regulatory compliance. The group’s historical development is therefore best understood as the transformation of a specialized analytical enterprise into a diversified, multinational testing platform, while retaining laboratory science as the core of its business.
- 1987
Eurofins founded
[1]Gilles Martin founded the business that developed into Eurofins Scientific, initially centered on analytical testing.
International laboratory network developed
[1]Eurofins expanded its geographic footprint and technical capabilities through the development and integration of specialist laboratories.
Public listing on Euronext Paris
[1]Eurofins Scientific became a publicly traded company on Euronext Paris under ticker ERF.PA.
Products and positioning
A global network of specialist laboratories providing independent analytical testing and related scientific services for health, safety, regulatory, and environmental applications.
Laboratory testing
Food and feed testing
Eurofins provides analytical services for food, ingredients, beverages, and feed. Testing can address microbiological safety, chemical contaminants, residues, allergens, nutritional composition, authenticity, and other quality or regulatory requirements. The exact panels and methods depend on the product, market, and applicable regulations.
Laboratory testing
Environmental testing
Environmental laboratories analyze samples such as water, soil, air, waste, and other materials for pollutants and regulated substances. These services support environmental monitoring, remediation, industrial compliance, public authorities, and health and safety programs.
Pharmaceutical laboratory services
Pharmaceutical and biopharmaceutical services
Eurofins companies support pharmaceutical and biopharmaceutical customers with analytical development, quality control, testing, validation, and related research services. Offerings vary by laboratory and may cover drug substances, drug products, biological materials, manufacturing processes, and regulatory requirements.
Clinical laboratory services
Clinical and genetic diagnostics
Eurofins operates clinical, pathology, molecular, and genetic testing businesses in selected markets. These services provide laboratory information for healthcare professionals, patients, researchers, and institutions, with the precise scope determined by local accreditation and medical regulation.
Consumer-product testing
Cosmetics and consumer-product testing
Eurofins laboratories test cosmetics and other consumer products for safety, composition, performance, microbiology, stability, and regulatory conformity. The services help manufacturers and brands assess products before and during commercialization.
Controversies
2025
Dutch Eurofins clinical laboratory suffers major data breach
A cyberattack affecting Eurofins Clinical Diagnostics NMDL in the Netherlands was reported to have exposed sensitive medical and identity information connected with a national cervical-cancer screening program. Reports said the incident involved data relating to approximately 485,000 participants and publication of a smaller subset on the dark web.
2025
Data breach at Dutch Clinical Diagnostics laboratory
A cyberattack involving Eurofins Clinical Diagnostics NMDL in the Netherlands was reported to have exposed sensitive medical and identity information from a national cervical-cancer screening program. Reports described data relating to approximately 485,000 participants and the publication of a smaller subset on the dark web.
2019
Ransomware attack disrupts Eurofins systems
A ransomware attack affected Eurofins information systems, taking servers and other systems offline. The disruption affected forensic operations and contributed to delays in court proceedings because laboratories were temporarily unable to process new samples.
2018
Eurofins QC sanctioned for falsified water-testing results
The Pennsylvania Department of Environmental Protection announced sanctions against Eurofins QC over falsification of whole-effluent-toxicity test results. The matter involved the reliability of environmental testing records and resulted in a reported $600,000 penalty.
Recent events
Eurofins acquired Gentis[5]
Eurofins Scientific announced that its subsidiary, Eurofins Clinical Testing Lux Sarl, had acquired Genetic Testing Service JSC (Gentis), a genetic testing company in Vietnam.
Reported
IATA and Eurofins partner on Covid-19 testing[6]
IATA signed an agreement with Eurofins to incorporate Eurofins’ worldwide Covid-19 testing network into IATA Travel Pass, making its Covid-19 testing portfolio available through the app.
Eurofins launches quantitative SARS-CoV-2 IgG assay[7]
Eurofins launched a CE-marked serological assay that identifies and quantifies antibodies to SARS-CoV-2. The article says the assay can support vaccination monitoring and detect antibodies resulting from natural infection.
- Unconfirmed
Reported
Eurofins makes COVID-19 test kits available in Germany and Spain[8]
Eurofins' EmpowerDx SARS-CoV-2 test kit became available to order in Germany through empowerdx.eu and the GeLaMed app, and in Spain through listed Eurofins websites. The source does not state when this availability began.
Reported
Eurofins launches validated mask filtration test method[9]
Eurofins Textile Testing Spain announced the launch and validation of a test method to evaluate mask filtration capacity using 100-nanometre particles. The release said this was the first such validated method in Europe and that the test was mandatory for masks sold in the North American market.
Eurofins acquires Gomti Life Sciences assets[10]
Eurofins, through Eurofins Advinus, acquired all assets of Gomti Life Sciences Private Limited, including a manufacturing facility in Bidadi Industrial Area, Bangalore, India.
Sources11 sources
- 1Eurofins official websiteeurofins.com
- 2Dutch Eurofins clinical laboratory suffers major data breachnltimes.nl
- 3Ransomware attack disrupts Eurofins systemsbbc.com
- 4Eurofins QC sanctioned for falsified water-testing resultsmedia.pa.gov
- 5Eurofins收购Gentisbiospectrumasia.com
- 6IATA与Eurofins合作提供新冠检测服务breakingtravelnews.com
- 7Eurofins推出定量SARS-CoV-2 IgG检测biospectrumindia.com
- 8Eurofins在德国和西班牙提供新冠检测套件finanznachrichten.de
- 9Eurofins 推出经验证的口罩过滤性能测试方法finanznachrichten.de
- 10Eurofins收购Gomti Life Sciences资产biospectrumindia.com
- 11Eurofins announces acquisition of all assets of Gomti Life Sciencesaninews.in
Cite this profile: Cite the canonical profile. /brand-wiki/eurofins · Editorial policy · How profiles are compiled